1. Proton pump inhibitors
Proton pump inhibitors (PPIs) such as omeprazole, lansoprazole, and pantoprazole are widely prescribed to reduce stomach acid for conditions like gastroesophageal reflux disease (GERD). However, long-term use beyond the recommended period can lead to significant cognitive risks.
PPIs may impair brain health by reducing absorption of vitamin B12, a crucial nutrient for nervous system function. Deficiency in B12 can result in memory loss, confusion, and other neurological symptoms. Large-scale observational studies have linked prolonged PPI use to an increased risk of dementia and cognitive decline.
Patients should limit PPI use typically to periods of two weeks up to three months unless otherwise advised by a healthcare professional. Regular review of medication necessity and monitoring vitamin B12 levels can help mitigate potential brain health risks.
2. Anticholinergics
Anticholinergic drugs block acetylcholine, a neurotransmitter essential for memory and learning. Commonly prescribed for Parkinson’s disease, urinary incontinence, and motion sickness, drugs such as oxybutynin, meclizine, and diphenhydramine have been associated with an increased risk of dementia.
Long-term use of these medications impairs cognitive function by disrupting neurotransmitter balance. A notable study tracking older adults found a 54% higher risk of dementia among regular users of anticholinergics. Not all drugs in this class carry the same risk; for example, glycopyrronium and tiotropium appear safer alternatives.
Decisions about anticholinergic use should carefully weigh the benefits against the potential for cognitive decline, especially in older adults or those with existing memory concerns.
3. Corticosteroids
Corticosteroids like prednisone are effective in treating inflammation and autoimmune conditions but carry notable risks for brain health when used long-term, particularly orally. They can alter cortisol levels, the body’s stress hormone, leading to symptoms such as anxiety, depression, and disorientation.
Chronic corticosteroid therapy has been linked to an elevated risk of dementia. Even inhaled corticosteroids, such as fluticasone, may pose risks if used in high doses or over an extended period. Monitoring by healthcare providers is essential to balance treatment benefits with cognitive side effects.
Alternative therapies or dose adjustments may reduce the impact on brain function, but any changes should be managed by a doctor.
